Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1b/II BGB-290 in comb w/ radiation and/or temozolomide w/ recurrent/refractory glioblastoma

Protocol: OSU-17310

Full Title

A Phase 1b/II study to assess the safety, tolerability and efficacy of BGB-290 in combination with radiation therapy and/or temozolomide in subjects with first-line or recurrent/refractory glioblastoma

Brain Cancer